WHAT YOU NEED TO KNOW: In an important step toward reining in Big Pharma, the Senate Judiciary Committee approved yesterday the bipartisan Affordable Prescriptions for Patients Act, sponsored by U.S. Senators John Cornyn (R-TX) and Richard Blumenthal (D-CT), despite pushback from Big Pharma. Matthew Lane, executive director of the Coalition Against Patent Abuse: “We thank […]

Continue Reading

Applauds Senators Cornyn and Blumenthal for their efforts to stop the major drug companies from abusing the U.S. patent system to delay or prevent patients from accessing more affordable generic alternative medications and treatments. WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market advocates […]

Continue Reading

Study Finds Average Annual Cost For Specialty Drugs Climbed To Almost $79,000 In 2017 WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market advocates and others released the following statement today in response to a new AARP report which found that the average […]

Continue Reading

by Matthew Lane, Coalition Against Patent Abuse American innovation and ingenuity are an essential driver of key medical advancements. They improve countless lives through a myriad of cures and treatments. But with increasingly expensive prescription drug prices and treatments, thanks in no small part to the exploitative behavior of groups like Big Pharma to extend […]

Continue Reading

Coalition thanks Representatives Jeffries, Collins, Mucarsel-Powell and Cline for introducing TERM Act, to stop major drug companies from using patent thickets to prevent affordable generic drugs and treatments from reaching American consumers WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market advocates and […]

Continue Reading

Good afternoon – In case you missed it, after several days of stinging testimony and growing public blowback against their proposed legislation that would overrule over 150 years of carefully crafted Supreme Court precedent on patent eligibility and open the floodgates to further abuses of the patent system by Big Pharma, Senators Tillis and Coons […]

Continue Reading

CAPA applauds Sen. Cornyn for standing up to Big Pharma and putting patients first IN CASE YOU MISSED IT: Bloomberg Government published this article today highlighting comments by CAPA’s Executive Director Matthew Lane applauding U.S. Senator John Cornyn and his efforts through the bipartisan legislation, the Affordable Prescriptions for Patients Act, he co-sponsored with Sen. Richard […]

Continue Reading

As the Senate Judiciary Committee kicks off a third hearing today on the Tillis/Coons legislation, several Big Pharma advocates have once again made it onto the witness list. These Big Pharma companies have been abusing patent laws for years – keeping more affordable generic medications off the market and out of the hands of patients. […]

Continue Reading

Coalition calls on Senators Tillis and Coons to amend their draft legislation and protect significant Supreme Court rulings on patents that restrict abuse by Big Pharma Click here to read CAPA’s full letter to Congress urging opposition to Tillis/Coons legislation WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, […]

Continue Reading

Coalition calls on Congress to oppose “poison pill” bill that would undo significant Supreme Court rulings on patent abuse and ultimately lead to increased prescription drug prices and reduced access to life-saving treatments   WASHINGTON, D.C. –  The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market […]

Continue Reading